US Patent 12091692 PH20 polypeptide variants, formulations and uses thereof
Patent 12091692 was granted and assigned to Halozyme, Inc. on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12091692 PH20 polypeptide variants, formulations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
